Lumos Pharma Inc. (LUMO)
4.34
0.00 (0.00%)
At close: Dec 11, 2024, 9:00 PM
Lumos Pharma Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| Net Income | -34.03M | -31.06M | -30.43M | -5.66M | -42.99M | -53.59M | -71.95M | -85.16M | -40.38M | 102.86M | -31.18M | -23.32M | -18.09M | -16.56M | -9.68M | -9.16M |
| Depreciation & Amortization | 44K | 49K | 203K | 584K | 1.09M | 1.15M | 1.41M | 2.08M | 1.59M | 1.1M | 891K | 788K | 687K | 655K | 303K | 294K |
| Stock-Based Compensation | 2.32M | 2.32M | 2.88M | 1.07M | 6.72M | 17.12M | 18.51M | 16.71M | 15.94M | 8.61M | 4.37M | 3.19M | 2.54M | 1.52M | 661K | 141K |
| Other Working Capital | 679K | 400K | -950K | -422K | 2.62M | 10.32M | 19.1M | -27.91M | -1.48M | -11.4M | 463K | -471K | 1.27M | 270K | -158K | 198K |
| Other Non-Cash Items | -392K | -26K | 14K | -5.87M | 371K | 102K | 126K | -397K | 15.94M | 8.61M | 4.37M | 3.19M | -1K | 1.02M | 661K | 5K |
| Deferred Income Tax | n/a | n/a | n/a | -9.5M | n/a | n/a | n/a | 3.96M | -15.94M | -8.61M | -4.36M | -3.16M | 1K | 350K | -661K | n/a |
| Change in Working Capital | 965K | 2.1M | -2.31M | -3.62M | 4.59M | -2.71M | 3.63M | -3.14M | -1.24M | -3.5M | 104K | -1.17M | 1.91M | -258K | -429K | -163K |
| Operating Cash Flow | -31.09M | -26.62M | -29.65M | -23M | -30.21M | -37.94M | -48.28M | -65.95M | -24.09M | 109.07M | -25.82M | -20.47M | -12.95M | -13.27M | -9.14M | -8.88M |
| Capital Expenditures | n/a | -21K | -30K | -30K | -2K | -7K | -43K | -2.25M | -4M | -1.7M | -1.39M | -1.32M | -281K | -2.93M | -1.4M | -427K |
| Acquisitions | n/a | n/a | n/a | 84.18M | n/a | 124K | 254K | n/a | n/a | 12.14M | -1.25M | -946K | 762K | n/a | n/a | n/a |
| Purchase of Investments | -7.38M | -11.34M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -17.38M | -249K | -1.99M | -2.49M | -277K | n/a | n/a |
| Sales Maturities Of Investments | 18.12M | n/a | n/a | n/a | n/a | n/a | n/a | 2.18M | 10.21M | 5.23M | 1.49M | 2.99M | 2.27M | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -11.34M | 26M | 32.5M | 79K | 124K | 254K | -66K | 6.22M | -12.14M | 1.25M | 996K | -762K | 500K | -142K | -2.7M |
| Investing Cash Flow | 10.74M | -11.36M | 25.97M | 116.65M | 77K | 117K | 211K | -66K | 6.22M | -13.84M | -141K | -277K | -502K | -2.71M | -1.54M | -3.13M |
| Debt Repayment | n/a | n/a | n/a | -27K | n/a | -167K | -246K | -257K | -194K | -90K | -215K | 227K | -218K | 940K | -9K | n/a |
| Common Stock Repurchased | -1.31M | -675K | -114K | n/a | -36K | -275K | -289K | -82K | -561K | -222K | n/a | -4K | 13K | -468K | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | -1K | n/a | n/a | n/a |
| Other Financial Acitivies | 9K | -146K | -114K | 102K | 58K | 294K | 1.41M | 2.22M | 10.31M | 6.63M | 858K | 1.13M | 5M | 8.78M | 19.62M | 17.91M |
| Financial Cash Flow | -576K | -821K | -192K | 75K | -59K | -148K | 75.29M | 1.88M | 23.09M | 33.89M | 67M | 1.51M | 42.37M | 11.33M | 19.63M | 17.93M |
| Net Cash Flow | -20.93M | -38.8M | -3.87M | 93.73M | -30.19M | -37.97M | 27.22M | -64.13M | 5.22M | 129.11M | 41.04M | -19.24M | 28.92M | -4.64M | 8.94M | 5.92M |
| Free Cash Flow | -31.09M | -26.64M | -29.68M | -23.03M | -30.21M | -37.95M | -48.32M | -68.19M | -28.08M | 107.37M | -27.2M | -21.79M | -13.23M | -16.2M | -10.54M | -9.31M |